Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1982
Stereoselectivity in the disposition and metabolism of the uricosuric-diuretic agent, indacrinone, in Rhesus monkeysA G Zacchei, M R Dobrinska, T I Wishousky, et al.The American Journal of Cardiology|October 8, 1999
Concomitant use of cytochrome P450 3A4 inhibitors and simvastatinP J Gruer, J M Vega, M F Mercuri, et al.Clinical Pharmacology and Therapeutics|February 1, 1983
Enterohepatic circulation of sulindac and metabolitesC A Dujovne, A Pitterman, W C Vincek, et al.Rapid Communications in Mass Spectrometry : RCM|January 1, 1996
The use of stable isotope labeling and liquid chromatography/tandem mass spectrometry techniques to study the pharmacokinetics and bioavailability of the antimigraine drug, MK-0462 (rizatriptan) in dogsA Barrish, T V Olah, G J Gatto, et al.Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1982
Pharmacokinetics of the pivaloyloxyethyl (POE) ester of methyldopa, a new prodrug of methyldopaM R Dobrinska, W Kukovetz, E Beubler, et al.Pharmaceutical Research|December 1, 1992
Influence of age and gender on the plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity following multiple doses of lovastatin and simvastatinH Cheng, J D Rogers, A E Sweany, et al.Biopharmaceutics & Drug Disposition|October 1, 1983
Biliary secretion of sulindac and metabolites in manM R Dobrinska, D E Furst, T Spiegel, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1984
Metabolism of methyldopa in man after oral administration of the pivaloyloxyethyl esterS Vickers, C A Duncan, H G Ramjit, et al.Journal of Medicinal Chemistry|June 1, 1984
3-Hydroxy-alpha-methyltyrosine progenitors: synthesis and evaluation of some (2-oxo-1,3-dioxol-4-yl)methyl estersW S Saari, W Halczenko, D W Cochran, et al.Pharmacogenetics|December 12, 2001
In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentrationY S Lin, G F Lockwood, M A Graham, et al.Pageof 3